Seelos Therapeutics Stock (NASDAQ: SEEL) stock price, news, charts, stock research, profile.
Open | $0.290 |
Close | - |
Volume / Avg. | 275.928K / 441.197K |
Day Range | 0.281 - 0.301 |
52 Wk Range | 0.290 - 49.800 |
Market Cap | $4.013M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 24 |
Short Interest | 5.42% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Seelos Therapeutics (NASDAQ: SEEL) through any online brokerage.
Other companies in Seelos Therapeutics’s space includes: Cingulate (NASDAQ:CING), 60 Degrees (NASDAQ:SXTP), Akanda (NASDAQ:AKAN), Palisade Bio (NASDAQ:PALI) and Sonoma Pharmaceuticals (NASDAQ:SNOA).
The latest price target for Seelos Therapeutics (NASDAQ: SEEL) was reported by Guggenheim on Friday, September 22, 2023. The analyst firm set a price target for 0.00 expecting SEEL to fall to within 12 months (a possible -100.00% downside). 10 analyst firms have reported ratings in the last year.
The stock price for Seelos Therapeutics (NASDAQ: SEEL) is $0.284 last updated Today at April 25, 2024 at 1:20 PM EDT.
There are no upcoming dividends for Seelos Therapeutics.
Seelos Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Seelos Therapeutics.
Seelos Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.